摘要
目的探讨血清白细胞介素-6 (IL-6)在慢性胰腺炎与胰腺癌患者中的表达。方法回顾性分析2018年6月-2019年6月河南大学第一附属医院收治的120例胰腺病患者的一般资料,依据疾病种类的不同,分为慢性胰腺炎组和胰腺癌组,各60例。对比两组患者IL-6阳性率及血清IL-6含量。结果胰腺癌组IL-6阳性率高于胰腺炎组,差异有统计学意义(P<0.05);胰腺癌组的血清IL-6含量高于胰腺炎组,差异有统计学意义(P<0.05)。结论血清IL-6在慢性胰腺炎与胰腺癌患者中的表达具有临床意义,胰腺癌患者的IL-6阳性率高于胰腺炎,且胰腺癌患者的血清IL-6含量高于慢性胰腺炎患者。
Objective To investigate the expression of serum IL-6(IL-6) in patients with chronic pancreatitis and pancreatic cancer. Methods The general data of 120 patients with pancreatic diseases treated in the hospital from June, 2018 to June, 2018 were analyzed retrospectively. According to the types of diseases, they were divided into chronic pancreatitis group(n=60) and pancreatic cancer group(n=60). The positive rate the content of IL-6 in serum were compared between the two groups. Results The positive rate of IL-6 in pancreatic cancer group was significantly higher than that in pancreatitis group(P<0.05), and the serum IL-6 content in pancreatic cancer group was higher than that in pancreatitis group(P<0.05). Conclusion The expression of serum IL-6 in patients with chronic pancreatitis and pancreatic cancer is of clinical significance. The positive rate of IL-6 in patients with pancreatic cancer is higher than that in patients with pancreatitis, and the content of serum IL-6 in patients with pancreatic cancer is higher than that in patients with chronic pancreatitis.
作者
吴飞
WU Fei(First Ward of General Surgery,The First Affiliated Hospital of Henan University,kaifeng,Henan,475001,China)
出处
《黑龙江医学》
2020年第1期28-29,共2页
Heilongjiang Medical Journal
关键词
胰腺癌
慢性胰腺炎
血清IL-6
Pancreatic cancer
Chronic pancreatitis
Serum IL-6
